Tirzepatide 5mg/0.6ml: moving up from the starter dose

You've finished the 2.5mg pen. Now what?

Picture the moment the plain, unbranded box arrives via DPD, tracking notification on your phone, pen inside, ready to go. If this is your second Mounjaro delivery, that pen contains your 5mg/0.6ml doses. The first month at 2.5mg was a settling-in period; your digestive system was adjusting to a medicine that slows gastric emptying and signals two separate gut-hormone receptors. Most people notice relatively modest appetite changes at 2.5mg. That changes at 5mg.

The titration logic is straightforward: start low so your body adjusts, then increase. The 2.5mg starter pen exists to reduce the likelihood of early nausea. The 5mg pen is where the clinical intent of the treatment really begins. Your prescriber will have confirmed the move is appropriate before you receive it, at nume, that review happens on the same day you request it, with a real clinician reading your notes, not an automated system.

The pen format does not change: each KwikPen holds four doses, so one pen covers one month. The concentration is 5mg per 0.6ml, a dose worth understanding in detail before you begin. You use the same injection sites (abdomen, thigh or upper arm) rotating each week. Storage is the same: refrigerated between 2–8°C. For the exact room-temperature window and handling details, the Mounjaro Summary of Product Characteristics on the electronic Medicines Compendium is the right reference, not any article online.

What changes at 5mg, and what the side-effect picture looks like

For many people, the jump from 2.5mg to 5mg is the first time the medicine feels genuinely different. Appetite signals shift more noticeably. Portions that felt normal start feeling like too much. Some people describe a reduced interest in food rather than willpower, that is the dual GIP/GLP-1 mechanism doing what the Mounjaro clinical programme was designed to do.

Side effects can also resurface. Nausea, looser stools, constipation, indigestion or burping are all common after a dose increase and are listed on the NHS tirzepatide medicines page. They tend to peak in the first few days and settle within one to two weeks for most people. Eating smaller portions, avoiding very fatty meals, staying well hydrated and injecting at the same time each week can all help. If symptoms are severe or persistent, contact your prescriber rather than stopping the pen.

The one situation to take seriously: severe, persistent abdominal pain that radiates to the back, with or without vomiting, needs prompt medical attention. The MHRA highlighted acute pancreatitis as a known but infrequent risk across GLP-1 medicines in a January 2026 Drug Safety Update, it's rare, but it warrants a clear rule: don't wait it out, call 111 or 999 depending on severity. You can also report any suspected side effects directly via the MHRA Yellow Card scheme.

Who moves to 5mg, and how that decision is made

The standard schedule moves from 2.5mg to 5mg after approximately four weeks, assuming the lower dose was tolerated. That's the licensed starting pathway described in the Mounjaro SmPC. In practice, titration is not mechanical: a prescriber looks at how tolerated the first pen was, whether there are any new health factors, and whether the increase is clinically appropriate at that point. Some people stay at 2.5mg a little longer if GI symptoms were significant. The schedule is a guide, not a conveyor belt.

Private eligibility for Mounjaro covers adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, raised cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A full look at the titration schedule covers how dose increases beyond 5mg work and what the upper doses can achieve. The NHS tirzepatide page provides an accessible overview of how the medicine is used and what to expect at each stage.

If you're considering starting treatment or are due a clinical review before moving up a dose, a free consultation with our prescribers is the right starting point. Understanding where 5mg sits in context (and whether the cost of ongoing treatment works for you) is part of making an informed decision.